Next Article in Journal
The Impact of Cardiovascular Rehabilitation on Psychophysiological Stress, Personality and Tryptophan Metabolism: A Randomized Pilot Feasibility Study
Previous Article in Journal
Antioxidant Activity in Gilthead Seabream (Sparus aurata L.) Fed with Diet Supplemented with Moringa
 
 
Article
Peer-Review Record

S-Methyl-L-Ergothioneine to L-Ergothioneine Ratio in Urine Is a Marker of Cystine Lithiasis in a Cystinuria Mouse Model

Antioxidants 2021, 10(9), 1424; https://doi.org/10.3390/antiox10091424
by Miguel López de Heredia 1,2,*, Lourdes Muñoz 3, Ciriaco Carru 4, Salvatore Sotgia 4, Angelo Zinellu 4, Carmen Serra 3, Amadeu Llebaria 3,5, Yukio Kato 6 and Virginia Nunes 1,2,7,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Antioxidants 2021, 10(9), 1424; https://doi.org/10.3390/antiox10091424
Submission received: 28 July 2021 / Revised: 30 August 2021 / Accepted: 31 August 2021 / Published: 7 September 2021

Round 1

Reviewer 1 Report

The authors investigated urinary markers to detect or diagnose cystine stones using a mouse model of cystinuria. This is a very interesting study and is well done. I have only a few questions about this study. My concerns are:

 

  1. Since this study uses a mouse model, the authors need to show how well this mouse model fits into human cystinuria to avoid objections caused by species-specific properties. Can the ratio of S-methyl-L-ergothioneine to L-ergothioneine in urine be measured with as much effort as the current method, crystalluria analysis, in patients with cystinuria?
  2. Can the author argue that this method still overcomes current diagnostic methods, despite differences due to species characteristics, such as the gender differences seen in this model?

Author Response

Please see the attachment

Author Response File: Author Response.docx

Reviewer 2 Report

Heredia et al. investigated the urinary S-methyl-L-ergothioneine to L-ergothioneine ratio in a cystinuria mouse model. It helps to discriminate between cystine lithiasis phenotypes and is considered a biomarker. I have some suggestions for this study.

1. Please provide the case numbers in each group (Slc7a9-/- male/female mouse model and WT male/female mouse model). Besides, the case numbers of L-Erg and S-Met-L-Erg levels measurement in each group are also needed.

2. The urine S-methyl-L-ergothioneine to L-ergothioneine ratio in clinical research could be discussed and strengthened the application.

3. Since the L-ergothioneine could be measured in blood, plasma, RBC, and urine, is it possible to measure circulating S-methyl-L-ergothioneine (whole blood or plasma)?

4. Urine S-Met-L-Erg / L-Erg ratio has an excellent performance in distinguishing stone former and non-stone former in overall mice. How about the receiver operator characteristic curve in male and female mice separately? Besides, urinary S-Met-L-Erg / L-Erg ratio could be presented in cystinuric mice at 3 and 6 months of age. Besides, sex stratification results of urinary S-Met-L-Erg / L-Erg ratio at 3 and 6 months of age could also be presented.

Author Response

Please see the attachment

Author Response File: Author Response.docx

Round 2

Reviewer 2 Report

All suggestions had been revised accordingly. I have no further comments for this paper.

Back to TopTop